228 related articles for article (PubMed ID: 18426384)
1. Application of drug delivery system to boron neutron capture therapy for cancer.
Yanagië H; Ogata A; Sugiyama H; Eriguchi M; Takamoto S; Takahashi H
Expert Opin Drug Deliv; 2008 Apr; 5(4):427-43. PubMed ID: 18426384
[TBL] [Abstract][Full Text] [Related]
2. Liposomal boron delivery for neutron capture therapy.
Nakamura H
Methods Enzymol; 2009; 465():179-208. PubMed ID: 19913168
[TBL] [Abstract][Full Text] [Related]
3. Boron neutron capture therapy of brain tumors: past history, current status, and future potential.
Barth RF; Soloway AH; Brugger RM
Cancer Invest; 1996; 14(6):534-50. PubMed ID: 8951358
[TBL] [Abstract][Full Text] [Related]
4. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy.
Wu G; Barth RF; Yang W; Lee RJ; Tjarks W; Backer MV; Backer JM
Anticancer Agents Med Chem; 2006 Mar; 6(2):167-84. PubMed ID: 16529539
[TBL] [Abstract][Full Text] [Related]
5. Boron neutron capture therapy of cancer: current status and future prospects.
Barth RF; Coderre JA; Vicente MG; Blue TE
Clin Cancer Res; 2005 Jun; 11(11):3987-4002. PubMed ID: 15930333
[TBL] [Abstract][Full Text] [Related]
6. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer.
Barth RF; Vicente MG; Harling OK; Kiger WS; Riley KJ; Binns PJ; Wagner FM; Suzuki M; Aihara T; Kato I; Kawabata S
Radiat Oncol; 2012 Aug; 7():146. PubMed ID: 22929110
[TBL] [Abstract][Full Text] [Related]
7. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of the high-LET radiations from the boron neutron capture [10B(n,α) 7Li] reaction determined for induction of chromosome aberrations and apoptosis in lymphocytes of human blood samples.
Schmid TE; Canella L; Kudejova P; Wagner FM; Röhrmoser A; Schmid E
Radiat Environ Biophys; 2015 Mar; 54(1):91-102. PubMed ID: 25428113
[TBL] [Abstract][Full Text] [Related]
9. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
10. Fluorinated borono-phenylalanine for optimizing BNCT: Enhancing boron absorption against hydrogen scattering for thermal neutrons.
Romanelli G; Capuani S; Onorati D; Ulpiani P; Preziosi E; Andreani C; Senesi R
Med Phys; 2024 Jan; 51(1):439-446. PubMed ID: 37956252
[TBL] [Abstract][Full Text] [Related]
11. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
12. Boron delivery agents for neutron capture therapy of cancer.
Barth RF; Mi P; Yang W
Cancer Commun (Lond); 2018 Jun; 38(1):35. PubMed ID: 29914561
[TBL] [Abstract][Full Text] [Related]
13. Boron neutron capture therapy for glioblastoma.
Yamamoto T; Nakai K; Matsumura A
Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
[TBL] [Abstract][Full Text] [Related]
14. Targeted drug delivery for boron neutron capture therapy.
Mehta SC; Lu DR
Pharm Res; 1996 Mar; 13(3):344-51. PubMed ID: 8692724
[TBL] [Abstract][Full Text] [Related]
15. Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
Chandra S; Ahmad T; Barth RF; Kabalka GW
J Microsc; 2014 Jun; 254(3):146-56. PubMed ID: 24684609
[TBL] [Abstract][Full Text] [Related]
16. Liposome-based delivery of a boron-containing cholesteryl ester for high-LET particle-induced damage of prostate cancer cells: a boron neutron capture therapy study.
Gifford I; Vreeland W; Grdanovska S; Burgett E; Kalinich J; Vergara V; Wang CK; Maimon E; Poster D; Al-Sheikhly M
Int J Radiat Biol; 2014 Jun; 90(6):480-5. PubMed ID: 24605770
[TBL] [Abstract][Full Text] [Related]
17. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
[TBL] [Abstract][Full Text] [Related]
19. Boron biodistribution for BNCT in the hamster cheek pouch oral cancer model: combined administration of BSH and BPA.
Garabalino MA; Heber EM; Monti Hughes A; Pozzi EC; Molinari AJ; Nigg DW; Bauer W; Trivillin VA; Schwint AE
Appl Radiat Isot; 2014 Jun; 88():64-8. PubMed ID: 24360859
[TBL] [Abstract][Full Text] [Related]
20. Selective boron delivery by intra-arterial injection of BSH-WOW emulsion in hepatic cancer model for neutron capture therapy.
Yanagie H; Dewi N; Higashi S; Ikushima I; Seguchi K; Mizumachi R; Murata Y; Morishita Y; Shinohara A; Mikado S; Yasuda N; Fujihara M; Sakurai Y; Mouri K; Yanagawa M; Iizuka T; Suzuki M; Sakurai Y; Masunaga SI; Tanaka H; Matsukawa T; Yokoyama K; Fujino T; Ogura K; Nonaka Y; Sugiyama H; Kajiyama T; Yui S; Nishimura R; Ono K; Takamoto S; Nakajima J; Ono M; Eriguchi M; Hasumi K; Takahashi H
Br J Radiol; 2017 Jun; 90(1074):20170004. PubMed ID: 28406315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
